Manager 20Dec2012: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Category:GO Managers | [[Category:GO Managers Meetings]] | ||
*'''Scope of GO'''. We have had a series of term requests from someone who works for the Ontology Adverse Events (OAE) who is using GO to annotate the action of specific chemicals (drugs), see [https://sourceforge.net/users/abrayguo/]. These processes are probably (but not necessarily) also carried out by proteins so we could probably add the terms on that basis, but the question is more general: to what degree do we as a project support this type of 'non-standard' annotation? And if not in GO, where else does it live? [Jane & David] | *'''Scope of GO'''. We have had a series of term requests from someone who works for the Ontology Adverse Events (OAE) who is using GO to annotate the action of specific chemicals (drugs), see [https://sourceforge.net/users/abrayguo/]. These processes are probably (but not necessarily) also carried out by proteins so we could probably add the terms on that basis, but the question is more general: to what degree do we as a project support this type of 'non-standard' annotation? And if not in GO, where else does it live? [Jane & David] | ||
Latest revision as of 16:01, 7 April 2014
- Scope of GO. We have had a series of term requests from someone who works for the Ontology Adverse Events (OAE) who is using GO to annotate the action of specific chemicals (drugs), see [1]. These processes are probably (but not necessarily) also carried out by proteins so we could probably add the terms on that basis, but the question is more general: to what degree do we as a project support this type of 'non-standard' annotation? And if not in GO, where else does it live? [Jane & David]